European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice

Contact Dermatitis - Tập 73 Số 4 - Trang 195-221 - 2015
Jeanne D. Johansen1, Kristiina Aalto‐Korte2, Tove Agner3, Klaus E. Andersen4, Andreas J. Bircher5, M. Bruze6, Alicia Cannavó7, Ana M. Giménez‐Arnau8, Margarida Gonçalo9, An Goossens10, Swen Malte John11, Carola Lidén12, Magnus Lindberg13, Vera Mahler14, Mihály Matura15, Thomas Rustemeyer16, Jørgen Serup3, Radosław Śpiewak17, Jacob P. Thyssen1, M. Vigan18, Ian R. White19, Mark Wilkinson20, Wolfgang Uter21
1Department of Dermato‐Allergology National Allergy Research Centre, Gentofte Hospital, University of Copenhagen 2900 Hellerup Denmark
2Occupational Medicine, Finnish Institute of Occupational Health, 00250, Helsinki, Finland.
3Department of Dermatology; Bispebjerg Hospital; University of Copenhagen; 2400 Copenhagen Denmark
4Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, 5000, Odense, Denmark.
5Allergy Unit, Department of Dermatology, University Hospital and University of Basel, 4031 Basel, Switzerland.
6Department of Occupational and Environmental Dermatology Skåne University Hospital, Lund University SE‐20502 Malmö Sweden
7Hospital Municipal de Vicente López ‘Profesor Bernard Houssay’ Buenos Aires Argentina
8Department of Dermatology Hospital del Mar, Universitat Autónoma de Barcelona 08003 Barcelona Spain
9Department of Dermatology University Hospital and Faculty of Medicine, University of Coimbra 3000-075 Coimbra Portugal
10Contact Allergy Unit, Department of Dermatology; University Hospital K. U. Leuven; B-3000 Leuven Belgium
11Department of Dermatology, Environmental Medicine, Health Theory; University of Osnabrueck; D-49069 Osnabrueck Germany
12Institute of Environmental Medicine, Karolinska Institutet, SE, 17177, Stockholm, Sweden
13Department of Dermatology University Hospital Örebro SE‐70185 Örebro Sweden
14Allergy Unit, Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
15Unit of Occupational and Environmental Dermatology, Centre for Occupational and Environmental Medicine, SLSO, SE-11365 Stockholm, Sweden.
16Department of Dermatology VU University Medical Centre 1081 HV Amsterdam The Netherlands
17Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
18Department of Dermatology CHRU Besançon 25030 Besançon Cedex France
19Department of Cutaneous Allergy; St John's Institute of Dermatology, St Thomas' Hospital; London SE1 7EH UK
20Spire Hospital, Leeds, LS8 1NT UK.
21Department of Medical Informatics, Biometry and Epidemiology University of Erlangen/Nürnberg 91054 Erlangen Germany

Tóm tắt

SummaryThe present guideline summarizes all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions and discussions of different pertinent topics are followed by a highlighted short practical recommendation. Topics comprise, after an introduction with important definitions, materials, technique, modifications of epicutaneous testing, individual factors influencing the patch test outcome or necessitating special considerations, children, patients with occupational contact dermatitis and drug eruptions as special groups, patch testing of materials brought in by the patient, adverse effects of patch testing, and the final evaluation and patient counselling based on this judgement. Finally, short reference is made to aspects of (continuing) medical education and to electronic collection of data for epidemiological surveillance.

Từ khóa


Tài liệu tham khảo

Lachapelle J M, 2009, Patch Testing, Prick Testing – a Practical Guide

Rietschel R, 2008, Fisher's Contact Dermatitis

10.1007/978-3-642-03827-3

Johansen J D, 2015, Quick Guide to Contact Dermatitis

10.1007/978-3-642-02035-3

10.1007/978-3-642-03827-3_24

10.1007/978-3-642-03827-3_22

10.1007/978-3-642-03827-3_26

10.1007/978-3-642-03827-3_39

10.1111/j.1600-0536.2011.01971.x

10.1111/j.1600-0536.2008.01502.x

10.1034/j.1398-9995.2000.00380.x

10.1111/j.1600-0536.1996.tb02412.x

Ring J, 1991, Angewandte Allergologie

10.1111/j.1600-0536.1984.tb00957.x

Cronin E, 1972, Clinical prediction of patch test results, Trans St Johns Hosp Dermatol Soc, 58, 153

10.1111/j.1600-0536.1984.tb01010.x

10.1111/j.1600-0536.1995.tb00534.x

10.1111/j.1600-0536.1999.tb06154.x

10.1111/cod.12240

Isakson M, 2015, Recommendation to include a textile dye mix into the European baseline series (On behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group), Contact Dermatitis, 73, 15, 10.1111/cod.12400

10.1111/j.0105-1873.2006.00863.x

10.1007/978-3-642-02035-3_82

10.1007/978-3-642-03827-3_57

de Groot A, 2008, Patch Testing. Test Concentrations and Vehicles for 4350 Chemicals

10.1111/j.1365-2133.2010.10087.x

10.1111/j.1600-0536.2011.02035.x

10.1111/cod.12300

10.1097/DER.0b013e3182a0a19d

10.1111/cod.12169

10.1016/j.toxlet.2005.10.008

10.1111/j.1600-0536.1979.tb04802.x

10.1111/j.1600-0536.1984.tb01011.x

10.1111/j.1600-0536.2011.02044.x

10.1111/j.1600-0536.2007.01098.x

10.1111/j.1600-0536.2010.01797.x

10.1111/j.1600-0536.1983.tb04623.x

10.1034/j.1600-0536.2000.042003144.x

10.1111/j.1365-2133.2012.11143.x

10.1034/j.1600-0536.2002.470603.x

10.1111/j.1600-0536.2007.00985.x

Bruze M, 2015, Quick Guide to Contact Dermatitis

10.1111/j.1365-2133.1996.tb07603.x

10.1097/01634989-199106000-00006

10.1111/j.1600-0536.1994.tb01925.x

10.1111/j.1600-0536.1998.tb05891.x

10.1111/j.1600-0536.1984.tb00057.x

Bruze M, 1988, Patch testing with nickel sulphate under occlusion for five hours, Acta Derm Venereol, 68, 361

10.1111/j.1600-0536.1999.tb05972.x

Friedmann P S, 1983, Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects, Clin Exp Immunol, 53, 709

10.1111/j.1600-0536.1996.tb02357.x

10.1111/j.1600-0536.1995.tb02070.x

Fregert S, 1974, Manual of Contact Dermatitis

10.1111/j.1365-2133.2006.07159.x

10.1034/j.1600-0536.2002.470207.x

Marmgren V, 2011, Successful photopatch testing with ketoprofen using one‐hour occlusion, Acta Derm Venereol, 91, 131, 10.2340/00015555-1029

Magnusson B, 1966, Routine patch testing. II. Proposed basic series of test substances for Scandinavian countries and general remarks on testing technique, Acta Derm Venereol, 46, 153

10.1111/j.1610-0387.2009.06787.x

10.1111/j.1365-2133.2009.09106.x

10.1046/j.1365-2133.2000.03362.x

10.1111/j.1600-0536.2012.02140.x

10.1111/j.1600-0536.1989.tb03121.x

10.1034/j.1600-0536.2000.042006330.x

10.1034/j.1600-0536.2000.042001027.x

10.1016/S1046-199X(96)90056-1

10.1111/j.1600-0536.2007.01252.x

10.1034/j.1600-0536.2001.045001043.x

10.1684/ejd.2009.0686

10.1034/j.1600-0536.2003.00033.x

10.1111/j.1600-0536.1992.tb05267.x

10.1111/j.1600-0536.2008.01360.x

10.1111/j.1365-2133.2004.06465.x

10.1111/j.1600-0536.1986.tb01229.x

10.1111/j.1600-0536.1998.tb05850.x

10.1034/j.1600-0536.2003.00126.x

10.1016/j.annder.2009.06.007

10.1111/j.1468-3083.2004.01053.x

10.1111/j.0105-1873.2006.00760.x

10.1111/cod.12037

10.1007/978-3-642-03827-3_29

10.1515/9783110837841

10.1007/978-3-642-03827-3_46

10.1111/j.1600-0536.1984.tb00144.x

10.1097/01634989-199209000-00004

10.1034/j.1600-0536.2003.00009.x

10.1111/j.1600-0536.1990.tb05003.x

10.1111/j.1600-0536.1984.tb00928.x

10.1111/j.1600-0536.1997.tb00920.x

10.1097/DER.0b013e318277ca50

10.1111/j.1600-0536.2011.01962.x

10.1111/j.0105-1873.2005.00565.x

10.1111/j.1600-0536.2010.01709.x

10.1111/j.1600-0536.2010.01856.x

10.1111/j.1600-0536.2010.01749.x

10.1111/cod.12101

10.1111/cod.12110

10.1111/cod.12111

10.1111/j.1365-2133.2010.10151.x

10.1007/978-3-642-03827-3_27

10.1111/j.1600-0536.2009.01607.x

Wilkinson D S, 1970, Terminology of contact dermatitis, Acta Derm Venereol, 50, 287

10.1111/j.1600-0536.2010.01710.x

10.1111/j.1600-0536.2009.01695.x

10.1111/j.0105-1873.2004.00340.x

10.1111/j.1365-2133.1972.tb01895.x

10.3109/09546634.2011.649243

10.1093/jnci/51.3.1075

10.1159/000250818

10.1016/0091-6749(75)90146-3

10.1073/pnas.89.18.8497

10.1046/j.1365-2249.1997.d01-944.x

10.1111/j.1365-2230.1980.tb01663.x

10.1046/j.1365-2133.2003.05112.x

Uter W, 2014, Filaggrin Molecules in Health and Disease, 251

10.1111/cod.12021

10.1111/cod.12129

10.1097/DER.0b013e318273a3e0

10.1097/DER.0000000000000037

10.1111/j.1600-0536.2011.01900.x

10.1007/978-3-642-03827-3_48

10.1111/j.1600-0536.2011.01930.x

10.1111/cod.12102

10.1111/cod.12322

10.1111/j.1600-0536.2009.01659.x

10.1007/s11882-014-0442-8

10.1111/j.1600-0536.2011.01946.x

10.1097/DER.0b013e31824a603d

10.1034/j.1600-0536.2001.450601.x

10.1111/all.12142

10.1111/bjd.12125

10.1111/j.0105-1873.2004.00280.x

10.1034/j.1600-0536.2002.470302.x

10.1016/j.jaip.2013.11.006

10.1111/j.1600-0536.2011.01942.x

10.1111/cod.12269

10.1034/j.1600-0536.2001.450401.x

10.1111/j.1600-0536.1984.tb00175.x

10.1111/j.1600-0536.1998.tb05659.x

10.1111/j.1600-0536.1988.tb05482.x

10.1111/j.1600-0536.2008.01457.x

10.1111/j.1600-0536.1999.tb06063.x

10.1111/j.1600-0536.2010.01761.x

10.1111/cod.12119

10.1034/j.1600-0536.2003.00081.x

10.1111/j.1600-0536.2011.01959.x

10.1111/j.1600-0536.2006.00952.x

10.1111/jdv.12292

Katta R, 2008, Common misconceptions in contact dermatitis counseling, Dermatol Online J, 14, 2, 10.5070/D39RF739T3

10.1111/j.1600-0536.2008.01326.x

10.1111/j.1600-0536.2010.01819.x

10.1111/j.1600-0536.2007.01170.x

10.1034/j.1600-0536.2003.00113.x

10.1111/j.0105-1873.2004.00442.x

10.1111/j.1365-2133.2005.06742.x

10.1111/cod.12143

10.1053/ajcd.2000.18394

10.1034/j.1600-0536.2002.470414_1.x

10.1097/DER.0b013e31826ea0d2

10.1111/j.1600-0536.1994.tb00646.x

10.1016/j.jaad.2006.11.034

10.1111/j.1600-0536.2011.02039.x

Chowdhury M M U, 2014, Draft: Cutaneous Allergy Post‐CCT Curriculum 2014 Version 13, updated 4/12/2013

10.1111/bjd.12256

10.1007/978-3-642-03827-3_54

Vigan M, 2002, REVIDAL‐GERDA: organization et collaboration avec la pharmacovigilance, Therapie, 57, 263

10.5414/DBP54160